- Latest available (Revised)
- Original (As adopted by EU)
Commission Delegated Regulation (EU) 2017/653 of 8 March 2017 supplementing Regulation (EU) No 1286/2014 of the European Parliament and of the Council on key information documents for packaged retail and insurance-based investment products (PRIIPs) by laying down regulatory technical standards with regard to the presentation, content, review and revision of key information documents and the conditions for fulfilling the requirement to provide such documents (Text with EEA relevance) (revoked)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
There are currently no known outstanding effects by UK legislation for Commission Delegated Regulation (EU) 2017/653.![]()
EUR 2017 No. 653 may be subject to amendment by EU Exit Instruments made by the Financial Conduct Authority under powers set out in The Financial Regulators' Powers (Technical Standards etc.) (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1115), regs. 2, 3, Sch. Pt. 1. These amendments are not currently available on legislation.gov.uk. Details of relevant amending instruments can be found on their website/s.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
CHAPTER I CONTENT AND PRESENTATION OF THE KEY INFORMATION DOCUMENT
CHAPTER II SPECIFIC PROVISIONS ON THE KEY INFORMATION DOCUMENT
Article 10.PRIIPs offering a range of options for investment
Article 11.‘What is this product’ section in the generic key information document
Article 12.‘What are the risks and what could I get in return?’ section in the generic key information document
Article 13.‘What are the costs?’ section in the generic key information document
Article 14.Specific information on each underlying investment option
CHAPTER III REVIEW AND REVISION OF THE KEY INFORMATION DOCUMENT
METHODOLOGY FOR THE PRESENTATION OF RISK
Specification of PRIIP categories for the purposes of the market...
Use of appropriate benchmarks or proxies to specify PRIIPs categories...
PART 2 Methodology for assessing credit risk
30. A PRIIP or its underlying investments or exposures shall be...
31. Where an entity directly engages to make a payment to...
33. For PRIIPs which are exposed to underlying investments or techniques,...
34. Where the credit risk is entailed solely at the level...
35. Where a PRIIP is exposed to multiple underlying investments entailing...
36. Underlying investments or exposures to exchange-traded derivatives or cleared OTC...
PART 3 Aggregation of market and credit risk into the summary risk...
Completion guidance with regard to the SRI
2. The narrative explanation after the SRI shall briefly explain the...
3. Immediately below the SRI, the time frame of the recommended...
4. As applicable for each PRIIP, the narrative explanation shall include:...
5. For PRIIPs offering a range of options for investment, PRIIP...
6. For derivatives that are futures, call options and put options...
Calculation of scenario values for the recommended holding period
4. The scenario values under different performance scenarios shall be calculated...
5. The unfavourable scenario shall be the value of the PRIIP...
7. The favourable scenario shall be the value of the PRIIP...
10. For Category 2 PRIIPs, the calculation of the stress scenario...
11. For Category 2 PRIIPs, the expected values at the end...
12. For Category 3 PRIIPs, the following adjustments shall be made...
13. For Category 3 PRIIPs, the following adjustments shall be made...
14. For Category 3 PRIIPs, the stress scenario shall be the...
17. For Category 1 PRIIPs, that are futures, call options and...
Calculation of expected values for intermediate holding periods
19. For PRIIPs with a recommended holding period between 1 and...
20. For PRIIPs with a recommended holding period of 3 years...
21. For PRIIPs with a recommended holding period of 1 year...
23. For Category 1 PRIIPs and Category 4 PRIIPs, the values...
24. For Category 3 PRIIPs, to produce the favourable, moderate, unfavourable...
25. For Category 1 PRIIPs that are futures, call options and...
26. For favourable, moderate and unfavourable scenarios at intermediate periods, the...
27. The unfavourable scenario shall be the estimate of the value...
28. The moderate scenario shall be the estimate of the value...
29. The favourable scenario shall be the estimate of the value...
30. The stress scenario shall be the estimate of the value...
METHODOLOGY FOR THE CALCULATION OF COSTS
I. LIST OF COSTS OF INVESTMENTS FUNDS (AIFs AND UCITS)
Calculation of specific types of costs of investments funds
12. The actual transaction costs for each transaction shall be calculated...
13. The net realised execution price shall be determined as the...
14. The arrival price shall be determined as the mid-market price...
15. Where information about the time when the order to transact...
16. Costs associated with transactions undertaken by PRIIPs and concerning financial...
17. In calculating the costs associated with foreign exchange, the arrival...
18. In calculating the costs associated with orders that are initially...
II. LIST OF COSTS OF PRIPS OTHER THAN INVESTMENT FUNDS
Calculation of implicit costs of PRIPs other than investment funds...
36. For the purposes of the calculation of the implicit costs...
37. The difference between the price and the fair value of...
39. The fair value policy that governs the measurement of the...
41. The fair value of a structured product shall be determined...
42. If the fair value cannot be derived from market prices,...
43. The valuation technique referred to in point 42 of this...
44. In the case of subscription products, the fair value shall...
45. Where preliminary terms are used, costs shall be calculated by...
46. Where variable subscription prices are used, a procedure on how...
III. LIST OF COSTS OF INSURANCE-BASED INVESTMENT PRODUCTS
Cost disclosure of the biometric risk premium of insurance based...
Costs part of biometric risk premiums
54. Biometric risk premiums are those premiums paid directly by the...
55. The fair value of biometric risk premiums is the expected...
56. Best estimate assumptions on future benefit payments from insurance coverage...
57. The estimated future benefit payments shall not include prudency margins...
58. For manufacturers within the scope of Directive 2009/138/EC these best...
59. The cost part of biometric risk premiums is the difference...
60. A PRIIP manufacturer may include the full biometric risk premiums...
PART 2 Summary cost indicators and compound effect of the costs
61. The summary cost indicator of the PRIIP is the reduction...
62. For the calculation of the summary cost indicator the costs...
Recurring costs, portfolio transaction costs and insurance costs/other recurring costs...
Incidental costs and incidental costs ratios (performance fees and carried...
Specific requirements for insurance-based investment products
II. COMPOUND EFFECT OF THE COSTS
The Whole Regulation you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including:
The data on this page is available in the alternative data formats listed: